INNOVAC PPR
Development of new-generation vaccines against “Peste des Petits Ruminants” (PPR, sheep and goat plague)
Available technology
Desired partnership(s)
- Licensing
IP
- Patent
Establishment(s)
- CIRAD
Laboratory(ies)
- UMR ASTRE (Animal, Health, Territories, Risks and Ecosystems)
Keywords
- “Peste des Petits Ruminants” (PPR, sheep and goat plague)
- Innovative vaccines
- DIVA (“Differentiating Infected from Vaccinated Animals”)
Context
“Peste du Petit Ruminant” (PPR), also known as sheep and goat plague, is a highly contagious disease caused by a virus in the Morbillivirus genus, belonging to the paramyxoviridae family. The disease currently affects nearly 70 countries. The worldwide population of small ruminant livestock is estimated at 2.1 billion animals, with annual losses due to PPR estimated at between $1.4 billion and $2.1 billion. The OIE (World Organization for Animal Health) and FAO (Food and Agriculture Organization) jointly developed a Global Strategy for the Control and Eradication of PPR. Vaccination campaigns are planned in that context. The Global Eradication Program includes about $500 million in vaccine purchases.
Benefits
Producing a DIVA (“Differentiating Infected from Vaccinated Animals”) vaccine to distinguish infected animals from vaccinated animals would be useful at all stages of the eradication effort. It is considered as a key part of the Global Eradication Program.
Applications
Vaccine against “Peste des Petits Ruminants” (PPR, sheep and goat plague)
AVAILABLE TECHNOLOGY | “Peste des Petits Ruminants” (PPR, sheep and goat plague) – Innovative vaccines – DIVA (“Differentiating Infected from Vaccinated Animals”)